United States · FDA National Drug Code directory
SILDENAFIL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-675_f4dbdb1b-c31d-4418-abd9-883eef04d5bd
- Product NDC
- 71610-675
- Form
- TABLET
- Composition / generic term
- SILDENAFIL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220701
- Source listing expiry
- 20261231
Source-listed ingredients
- SILDENAFIL CITRATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TABLET in 1 BOTTLE (71610-675-02) · 71610-675-02
- 9 TABLET in 1 BOTTLE (71610-675-03) · 71610-675-03
- 4 TABLET in 1 BOTTLE (71610-675-04) · 71610-675-04
- 6 TABLET in 1 BOTTLE (71610-675-06) · 71610-675-06
- 12 TABLET in 1 BOTTLE (71610-675-12) · 71610-675-12
- 3 TABLET in 1 BOTTLE (71610-675-33) · 71610-675-33
- 18 TABLET in 1 BOTTLE (71610-675-52) · 71610-675-52
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →